Topical PVDF/Sirolimus

A topical formulation consisting of a polyvinylidene fluoride (PVDF) polymer resin containing the macrolide sirolimus (rapamycin), produced by the organism Streptomyces hygroscopicus, with immunosuppressive activity. Upon application of topical PVDF/sirolimus, sirolimus migrates from the PVDF polymer resin into the skin. Once inside cells, sirolimus binds to the immunophilin FK binding protein-12 (FKBP-12) and forms a sirolimus:FKBP-12 complex. This complex binds to and inhibits the activity of the serine/threonine kinase mammalian target of rapamycin (mTOR), which may result in the suppression of cytokine-driven T-cell activation and proliferation. (NCI Thesaurus)

YOU MAY ALSO LIKE

Topical Preparation

Natural or synthetic compounds or mixtures that are applied to body surfaces such as the skin, mouth, vagina, lips, nose, ears or…

Topical Powder Spray Dosage Form

A powder spray intended for administration to the skin.

Topical Powder Dosage Form

A powder intended for administration to a body surface.

Topical Piperidine Nitroxide MTS-01

A topical gel containing a cell permeable hydrophilic piperidine nitroxide with potential radioprotective and antioxidant activity. As a stable, free radical compound,…

Topical Phenylephrine Solution

A topical solution containing phenylephrine, a sympathomimetic amine with vasoconstricting activity. Upon topical application to the oral mucosa, phenylephrine may activate alpha-adrenergic…

Topical Ointment Dosage Form

A ointment intended for administration to a body surface.